Envista Holdings Corp

Healthcare · Medical Instruments & Supplies

24.10$ +1.0% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Income Statement

Envista Holdings Corp (NVST) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 731 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement NVST
Line item	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	LTM
Revenue	673	733	680	759	660	712	659	721	547	362	547	616	613	637	607	652	631	646	631	661	627	662	631	646	624	633	601	653	617	682	670	751	706	731	2,857
Cost of Revenue	297	310	299	329	296	318	292	330	266	179	236	268	251	266	250	280	258	269	263	277	263	279	267	307	266	303	284	280	281	312	295	338	315	324	1,271
Gross Profit	376	423	381	430	364	395	367	390	281	183	312	348	361	372	357	372	374	377	368	384	364	383	364	339	358	330	317	373	336	370	375	413	390	407	1,585
Research & Development	42	44	42	44	43	40	36	35	35	17	20	23	26	26	24	25	24	25	26	25	25	27	22	20	23	24	26	27	25	28	28	32	30	30	121
Selling, General & Administrative	–	563	275	275	275	278	252	276	259	197	248	259	259	283	251	272	258	280	264	254	266	273	258	260	285	303	271	278	263	295	284	286	294	296	1,160
Total Operating Expenses	327	322	300	362	319	319	289	312	306	213	250	275	266	288	276	326	282	312	294	296	292	305	281	541	310	1,483	297	327	297	319	310	337	328	327	1,302
Operating Income	49	101	81	68	45	76	79	78	-25	-30	62	74	95	83	82	46	92	65	75	88	72	79	83	-203	48	-1,153	21	46	39	51	65	76	63	80	283
Interest Expense	–	–	0.0	0.0	0.2	0.0	0.2	3.3	3.3	15	23	21	18	14	12	11	5.9	6.4	12	15	17	17	15	14	13	12	12	9.9	9.3	8.0	9.0	10	7.4	8.7	35
Pre-Tax Income	49	101	83	68	45	77	79	75	-28	-122	38	51	77	70	70	37	86	59	63	76	56	69	36	-215	35	-1,166	9.6	37	29	41	50	58	52	74	234
Income Tax Expense	12	22	19	17	7.1	16	17	19	-11	-29	15	-40	16	-9.0	-10	-5.3	16	15	14	2.2	12	17	14	2.4	12	-15	1.4	35	11	14	80	25	14	21	139
Net Income	37	79	64	51	38	62	62	56	-17	-94	36	108	72	90	93	86	75	47	48	74	44	52	22	-217	24	-1,152	8.2	1.2	18	26	-30	33	39	54	95
EBITDA	82	133	115	161	79	115	113	114	19	-68	114	163	135	122	121	119	127	115	120	165	113	126	123	101	87	40	52	87	75	79	88	97	83	83	351

LTM = last twelve months (sum of the four most recent quarters).

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Income Statement

Cookie settings